Position in PFE
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,307,447
-$96,496 QoQ
Shares Held
54,296
+8.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#1,166
of 2,826 holders
Holding Since
Sep 2023
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ABN AMRO Bank N.V. holds $652,644,611 across 8 Drug Manufacturers - General names. PFE ranks #8 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AZN |
Astrazeneca PLC
|
1,592,396 | $301,950,129 | |
| 2 | LLY |
ELI LILLY & Co
|
164,869 | $197,748,841 | |
| 3 | ABBV |
AbbVie Inc.
|
394,664 | $99,313,248 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
191,290 | $24,167,578 | |
| 5 | MRK |
Merck & Co., Inc.
|
136,228 | $17,505,298 | |
| 6 | JNJ |
Johnson & Johnson
|
36,256 | $9,207,936 | |
| 7 | AMGN |
Amgen Inc
|
3,988 | $1,444,134 | |
| 8 | PFE |
Pfizer Inc
This page
|
54,296 | $1,307,447 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,307,447 | 54,296 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $1,403,943 | 49,998 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $697,150 | 27,998 | Shares | Sole | 2026-02-04 | |
| 2025-09-30 | $322,908 | 12,673 | Shares | Sole | 2025-11-05 | |
| 2024-09-30 | $201,798 | 6,973 | Shares | Sole | 2025-08-28 | |
| 2023-12-31 | $331,286 | 11,507 | Shares | Sole | 2025-08-28 | |
| 2023-09-30 | $405,403 | 12,222 | Shares | Sole | 2025-08-28 | |
| No filing history on record for this holder in this stock. | ||||||